The People's Insurance Company (Group) of China Limited (HKG:1339)
5.44
-0.08 (-1.45%)
May 22, 2026, 4:08 PM HKT
HKG:1339 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 573,061 | 570,717 | 537,709 | 503,900 | 468,802 | 529,891 |
Total Interest & Dividend Income | 12,075 | 69 | 1,533 | 17,086 | 10,713 | 38,708 |
Gain (Loss) on Sale of Investments | 13,793 | 34,445 | 25,166 | -13,565 | -5,185 | 11,501 |
Other Revenue | 19,089 | 18,837 | 17,122 | 17,906 | 18,493 | 14,448 |
| 618,018 | 624,068 | 581,530 | 525,327 | 492,823 | 594,548 | |
Revenue Growth (YoY) | 3.75% | 7.32% | 10.70% | 6.59% | -17.11% | 2.13% |
Policy Benefits | 535,210 | 533,543 | 500,301 | 479,397 | 439,680 | 423,403 |
Policy Acquisition & Underwriting Costs | - | - | - | - | - | 50,939 |
Selling, General & Administrative | 11,927 | 11,833 | 9,131 | 9,224 | 7,752 | 90,360 |
Provision for Bad Debts | -15 | 47 | -65 | -6 | - | - |
Other Operating Expenses | -266 | -338 | -397 | -438 | -434 | 1,566 |
Total Operating Expenses | 546,900 | 545,129 | 509,031 | 488,252 | 447,079 | 566,926 |
Operating Income | 71,118 | 78,939 | 72,499 | 37,075 | 45,744 | 27,622 |
Interest Expense | -1,337 | -1,260 | -1,471 | -1,463 | -2,206 | -5,460 |
Earnings From Equity Investments | - | - | - | - | - | 13,571 |
Currency Exchange Gain (Loss) | -513 | -308 | 64 | 228 | 1,002 | -331 |
Other Non Operating Income (Expenses) | -112 | -132 | -69 | -60 | -205 | - |
EBT Excluding Unusual Items | 69,156 | 77,239 | 71,023 | 35,780 | 44,335 | 35,402 |
Gain (Loss) on Sale of Investments | -664 | -664 | - | - | - | - |
Gain (Loss) on Sale of Assets | 130 | 110 | 174 | 209 | 321 | 330 |
Asset Writedown | -880 | -880 | -472 | -463 | -182 | -143 |
Other Unusual Items | -2,588 | -1,853 | -1,493 | -1,969 | -1,757 | - |
Pretax Income | 65,154 | 73,952 | 69,232 | 33,557 | 42,717 | 35,589 |
Income Tax Expense | 8,132 | 11,501 | 12,451 | 2,746 | 7,270 | 5,219 |
Earnings From Continuing Ops. | 57,022 | 62,451 | 56,781 | 30,811 | 35,447 | 30,370 |
Minority Interest in Earnings | -14,850 | -16,244 | -14,630 | -8,489 | -10,065 | -8,894 |
Net Income | 42,172 | 46,207 | 42,151 | 22,322 | 25,382 | 21,476 |
Net Income to Common | 42,172 | 46,207 | 42,151 | 22,322 | 25,382 | 21,476 |
Net Income Growth | -8.39% | 9.62% | 88.83% | -12.06% | 18.19% | 7.19% |
Shares Outstanding (Basic) | 44,165 | 44,224 | 44,224 | 44,224 | 44,224 | 44,224 |
Shares Outstanding (Diluted) | 44,745 | 44,224 | 44,224 | 44,224 | 44,224 | 44,224 |
Shares Change (YoY) | 1.47% | - | - | - | - | - |
EPS (Basic) | 0.95 | 1.04 | 0.95 | 0.50 | 0.57 | 0.49 |
EPS (Diluted) | 0.90 | 1.00 | 0.91 | 0.48 | 0.56 | 0.49 |
EPS Growth | -10.83% | 9.17% | 91.67% | -14.14% | 14.33% | 7.92% |
Free Cash Flow | 92,738 | 113,905 | 83,593 | 66,976 | 64,545 | 69,076 |
Free Cash Flow Per Share | 2.07 | 2.58 | 1.89 | 1.51 | 1.46 | 1.56 |
Dividend Per Share | 0.220 | 0.220 | 0.180 | 0.156 | 0.166 | 0.164 |
Dividend Growth | 22.22% | 22.22% | 15.38% | -6.02% | 1.22% | 5.13% |
Operating Margin | 11.51% | 12.65% | 12.47% | 7.06% | 9.28% | 4.65% |
Profit Margin | 6.82% | 7.40% | 7.25% | 4.25% | 5.15% | 3.61% |
Free Cash Flow Margin | 15.01% | 18.25% | 14.37% | 12.75% | 13.10% | 11.62% |
EBITDA | 73,884 | 81,661 | 75,045 | 39,635 | 48,370 | 30,144 |
EBITDA Margin | 11.96% | 13.08% | 12.90% | 7.54% | 9.81% | 5.07% |
D&A For EBITDA | 2,766 | 2,722 | 2,546 | 2,560 | 2,626 | 2,522 |
EBIT | 71,118 | 78,939 | 72,499 | 37,075 | 45,744 | 27,622 |
EBIT Margin | 11.51% | 12.65% | 12.47% | 7.06% | 9.28% | 4.65% |
Effective Tax Rate | 12.48% | 15.55% | 17.98% | 8.18% | 17.02% | 14.67% |
Revenue as Reported | 669,254 | 669,254 | 622,220 | 553,467 | 528,527 | 594,606 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.